On Friday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: Extreme Networks, (NASDAQ:EXTR), Career Education (NASDAQ:CECO),Corcept Therapeutics (NASDAQ:CORT), Kandi Technologies Group (NASDAQ:KNDI)
Extreme Networks, Inc (NASDAQ:EXTR) decreased -4.31%, and closed at $3.33. The company holds the market capitalization of $330.76 M. For the last twelve months, the stock was able to keep return on equity at -49.20%, while return on assets at -14.80%, in response to its return on investment at -19.50%. Its 20-day moving average decreased -2.22%, above 50-day moving average of 2.07%, below 200-day moving average of -16.49% from the latest market price of $3.33. The mean recommendation of analysts for this stock is 2.00. (Where 1=Buy, 5=Sale).
Extreme Networks, Inc (EXTR) together with its subsidiaries, provides wired and wireless network infrastructure equipment, software, and services for enterprises, data centers, and service providers.
Career Education Corp. (NASDAQ:CECO) declined -4.28%, and closed at $5.59. The company has the market capitalization of $377.44 million. The beta value of the stock is 2.44. On the other hand the stock’s volatility for the week is 4.16%, and for the month is 4.38%. The stock’s price to book ratio is $1.33, however price to sale ratio is $0.51. Analyst’s mean recommendation regarding this stock is 2.60. (Where 1=Buy, 5=Sale).
Career Education Corp. (CECO) operates colleges, institutions, and universities that provide education to student population in various career-oriented disciplines through online, on-ground, and hybrid learning program offerings in the United States.
Corcept Therapeutics Incorporated (NASDAQ:CORT) decreased -4.27%, and closed at $5.60. The stock has price to sale ratio of 21.35. With recent decline, the year-to-date (YTD) performance reflected a 89.19% incline above last year. During the past month the stock gain -66.17%, bringing three-month performance to 81.82% and six-month performance to 103.64%. The mean recommendation of analysts for this stock is 3.00 (where 1=Buy, 5=Sale).
Corcept Therapeutics Incorporated (CORT) a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol.
Kandi Technologies Group Inc (NASDAQ:KNDI) shares picked down -4.22%, and closed at $12.47. The stock volatility for the week is 5.44%, while for the month remained 3.99%. The company holds consensus target price of $4.59.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed -0.17 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained -405.00% and Annual EPS growth for the past 5 years is considered as -36.00%.
Kandi Technologies Group Inc (KNDI) through its subsidiaries, designs, develops, manufactures, and commercializes various vehicles. It offers electrical vehicles, all-terrain vehicles, go-karts, and specialized automobiles; and utility vehicles, three-wheeled motorcycles, refitted cars, and various auto generators.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
